Published in Dig Dis Sci on May 01, 1997
Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut (2001) 1.90
Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol (2006) 1.39
Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and disease. Dig Dis Sci (2005) 0.90
ERBBs in the gastrointestinal tract: recent progress and new perspectives. Exp Cell Res (2008) 0.89
Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits. Dig Dis Sci (2001) 0.87
Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats. Dig Dis Sci (2006) 0.85
Pepsin and the esophagus. Yale J Biol Med (2000) 0.83
Orally administered L-arginine and glycine are highly effective against acid reflux esophagitis in rats. Med Sci Monit (2012) 0.82
Animal model of acid-reflux esophagitis: pathogenic roles of acid/pepsin, prostaglandins, and amino acids. Biomed Res Int (2014) 0.78
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol (2015) 0.77
Ischemic heart disease, factor predisposing to Barrett's adenocarcinoma: A case control study. World J Gastrointest Pharmacol Ther (2014) 0.75
Reflux laryngitis in a patient with Zollinger Ellison syndrome and the role of epidermal growth factor. Dig Dis Sci (2004) 0.75
Epidermal growth factor. J Biol Chem (1990) 4.79
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med (1983) 3.04
Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest (1983) 2.24
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res (1984) 2.17
Impact of acid and pepsin on human esophageal prostaglandins. Am J Gastroenterol (1994) 1.75
Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol (1983) 1.68
Structural and functional adaptation following jejunal resection in rabbits: effect of epidermal growth factor. Gastroenterology (1994) 1.67
Aspirin renders the oesophageal mucosa more permeable to acid and pepsin. Eur J Gastroenterol Hepatol (1995) 1.52
Mitotic rates and renewal times of the digestive tract epithelia in the rat. Acta Anat (Basel) (1960) 1.48
Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology (1994) 1.37
Interaction between oxygen radicals and gastric mucin. Am J Physiol (1987) 1.21
Alkaline esophagitis: a comparison of the ability of components of gastroduodenal contents to injure the rabbit esophagus. Gastroenterology (1983) 1.20
Epidermal growth factor receptors in the oesophagus. Gut (1992) 1.15
Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. Cancer Res (1989) 1.09
Epidermal growth factor stimulates synthesis and secretion of mucus glycoproteins in human gastric mucosa. Clin Sci (Lond) (1990) 1.07
Epidermal growth factor in the oesophagus. Gut (1992) 1.01
Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression. Gut (1992) 0.99
H+ back diffusion interferes with intrinsic reactive regulation of esophageal mucosal blood flow. Surgery (1984) 0.97
Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins. Gastroenterology (1988) 0.97
Esophageal blood flow in the cat. Normal distribution and effects of acid perfusion. Gastroenterology (1986) 0.97
Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand J Gastroenterol (1992) 0.96
Stimulation of rat oxyntic gland mucosal growth by epidermal growth factor. Am J Physiol (1980) 0.92
Effect of epidermal growth factor on gastric blood flow in rats: possible role in mucosal protection. Gastroenterology (1993) 0.91
Gene expression in Barrett's mucosa: acute and chronic adaptive responses in the oesophagus. Gut (1993) 0.89
Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation. Gut (1994) 0.87
Tyrosine kinase activities in the modulation of stimulated parietal cell acid secretion. Am J Physiol (1993) 0.87
Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis. Am J Gastroenterol (1994) 0.85
Role of gastric blood flow, neutrophil infiltration, and mucosal cell proliferation in gastric adaptation to aspirin in the rat. Gut (1994) 0.85
Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits. Gut (1990) 0.84
Sucralfate prevents experimental peptic esophagitis in rabbits. Gastroenterology (1985) 0.84
Hydrochloric acid. A trigger of cell proliferation in the esophagus of dogs. Dig Dis Sci (1985) 0.84
Regulation of distal esophageal mucosal blood flow: the roles of nitric oxide and substance P. Surgery (1993) 0.82
Gastric adaptation to nonsteroidal anti-inflammatory drugs in man. Scand J Gastroenterol Suppl (1992) 0.81
Comparison of different monoclonal antibodies for the immunohistochemical assessment of cell proliferation in routine colorectal biopsy specimens. Scand J Gastroenterol (1994) 0.81
Evidence on secretion of epidermal growth factor by the esophageal mucosa in humans. Am J Gastroenterol (1993) 0.81
Esophageal epithelial defenses against acid injury. Am J Gastroenterol (1994) 0.78
Adaptation of the gastric mucosa to stress. Role of prostaglandin and epidermal growth factor. Scand J Gastroenterol Suppl (1992) 0.77
The esophageal mucosal resistance: structure and function of an unique gastrointestinal epithelial barrier. J Lab Clin Med (1994) 0.76
Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol (1997) 3.31
Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol (2000) 2.58
Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med (2000) 1.96
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther (2005) 1.95
What should we weigh to estimate heterozygosity, alleles or loci? Mol Ecol (2006) 1.85
The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J Virol (2001) 1.71
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis (2001) 1.67
Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology (1997) 1.63
SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res (2000) 1.55
Aspirin renders the oesophageal mucosa more permeable to acid and pepsin. Eur J Gastroenterol Hepatol (1995) 1.52
Risk factors associated with refractory peptic ulcers. Gastroenterology (1995) 1.47
Diabetic control in 102 insulin-treated out-patients. Diabetologia (1980) 1.47
The role of fibroblasts in organization and degradation of a fibrin clot. J Lab Clin Med (1991) 1.42
Reversibility of thrombin-induced decrease in platelet glycoprotein Ib function. Br J Haematol (1993) 1.40
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci U S A (1998) 1.37
Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther (2002) 1.33
Coronavirus derived expression systems. J Biotechnol (2001) 1.32
Diaphragm disease of the small bowel: a case without apparent nonsteroidal antiinflammatory drug use. J Clin Gastroenterol (2001) 1.24
Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. Gastroenterology (1999) 1.17
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood (1987) 1.16
Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment. Thromb Haemost (1984) 1.16
Fenofibrate inhibits angiogenesis in vitro and in vivo. Cell Mol Life Sci (2003) 1.12
Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Ther (1998) 1.10
New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects. Br J Cancer (2003) 1.10
Glycosylated haemoglobin concentrations and clinitest results in insulin-dependent diabetes. Lancet (1977) 1.09
Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler Thromb Vasc Biol (2001) 1.08
Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. Gut (1997) 1.07
Vasculogenic mimicry of acute leukemic bone marrow stromal cells. Leukemia (2009) 1.06
Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci U S A (2000) 1.06
Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core. J Virol (2001) 1.04
Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett (2001) 1.03
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum Gene Ther (2006) 1.03
Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis. Blood (1989) 1.03
Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost (1999) 1.02
Sebaceous carcinoma of the vulva. Am J Dermatopathol (1999) 1.01
Expression of the TIGR gene in the iris, ciliary body, and trabecular meshwork of the human eye. Ophthalmic Genet (2000) 0.99
Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p 24). Inhibition of aggregation by ALB6Fab. FEBS Lett (1983) 0.99
Measles virus fusion protein is palmitoylated on transmembrane-intracytoplasmic cysteine residues which participate in cell fusion. J Virol (1998) 0.99
Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation. Thromb Haemost (1988) 0.99
Fibrinogen synthesis by megakaryocyte rich human marrow cell concentrates. Thromb Res (1985) 0.97
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood (1987) 0.97
Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. Biophys J (1996) 0.97
Tumor necrosis factor induces acute phase proteins in rats. J Biol Regul Homeost Agents (1988) 0.95
Pituitary response to synthetic LH-RH in Stein-Leventhal syndrome and functional amenorrhea. Obstet Gynecol (1973) 0.94
Effectf of synthetic luteinizing hormone-releasing hormone (LH-RH) in two brothers with hypogonadotropic hypogonadism and anosmia. J Clin Endocrinol Metab (1973) 0.94
Differential gene expression in the human ciliary epithelium. Prog Retin Eye Res (1999) 0.93
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation (2001) 0.93
D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy. Prognostic significance for the success of anti-cancer treatment. Cancer (1992) 0.93
Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest (1993) 0.93
Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation. Thromb Haemost (1984) 0.92
Steroid production by gonadal tumors in male pseudo-hermaphroditism with isolated clitoromegaly. Biochemical studies in vivo. Steroidologia (1971) 0.92
Microglial tyrosine phosphorylation systems in normal and degenerating brain. Glia (1994) 0.92
Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies. Diabetes Res Clin Pract (2000) 0.92
Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness. Br J Cancer (2003) 0.91
Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol (1999) 0.90
Isolation and characterization of cell-specific cDNA clones from a subtractive library of the ocular ciliary body of a single normal human donor: transcription and synthesis of plasma proteins. J Biochem (1995) 0.90
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis. Thromb Haemost (2000) 0.90
Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol). Thromb Haemost (1991) 0.89
Ovarian refractoriness during lactation in women: effect of gonadotropin stimulation. Am J Obstet Gynecol (1972) 0.89
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. J Clin Invest (1988) 0.88
A new type of congenital dysfibrinogenaemia with defective fibrin lysis--Dusard syndrome: possible relation to thrombosis. Br J Haematol (1983) 0.88
New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity. FEBS Lett (1988) 0.88
Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits. Dig Dis Sci (2001) 0.87
Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. Gut (1996) 0.87
Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine. J Clin Endocrinol Metab (1973) 0.87
Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk. Haemostasis (1996) 0.87
Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells. Vascul Pharmacol (2004) 0.87
Cytologic features of pulmonary hamartoma. Report of a case diagnosed by fine needle aspiration cytology. Acta Cytol (2001) 0.86
Cytokine effects on pepsinogen secretion from human peptic cells. Gut (1997) 0.86
Study of acquired dysfibrinogenaemia in liver disease. Thromb Res (1981) 0.86
The effect of oral administration of thyrotropin-releasing hormone on lactation. J Clin Endocrinol Metab (1976) 0.86
Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. N Engl J Med (1981) 0.86
Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia. Thromb Diath Haemorrh (1972) 0.85
Nitric oxide and superoxide anion in low-grade esophagitis induced by acid and pepsin in rabbits. Dig Dis Sci (2000) 0.85
Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology. Br J Haematol (1985) 0.84
[A new case of Congenital and familial dysfibrinogenemia without Hemorrhagic Diathesis]. Thromb Diath Haemorrh (1971) 0.84
Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells. FEBS Lett (1996) 0.84
Apigenin inhibits endothelial-cell proliferation in G(2)/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression. Int J Cancer (2000) 0.84
Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium. Br J Ophthalmol (2002) 0.84
[Congenital and familial dysfibrinogenemia without hemorrhagic tendancy]. Nouv Rev Fr Hematol (1970) 0.83
Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells. Biochem Biophys Res Commun (1988) 0.83
Lipomatous polyposis of the colon. Br J Surg (1993) 0.83
The plasminogen-activation system in ovarian tumors. Int J Cancer (1993) 0.83
Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL-4, IL-10 and IL-13: consequences on cell adhesion to vitronectin and fibrinogen. Br J Haematol (1998) 0.83
[Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference]. Med Clin (Barc) (2000) 0.83
Altered cellular membrane fluidity levels and lipid peroxidation during experimental pancreas transplantation. J Bioenerg Biomembr (2012) 0.83
Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts. Curr Eye Res (2007) 0.83
Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation. Endoscopy (2010) 0.83
Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen). Thromb Res (1987) 0.82
Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma. Aliment Pharmacol Ther (2009) 0.82
Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways. Biochem Biophys Res Commun (2006) 0.82
Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice. Hum Gene Ther (1999) 0.82
Prognostic value of lymph node micrometastasis in patients with colorectal cancer in Dukes stages A and B (T1-T4, N0, M0). Rev Esp Enferm Dig (2010) 0.82
Non-steroidal anti-inflammatory drugs and prostaglandin effects on pepsinogen secretion by dispersed human peptic cells. Gut (1995) 0.82
Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Br J Haematol (1996) 0.82